Lapatinib and gemcitabine for metastatic pancreatic cancer. A phase II study.
Safran H, Miner T, Bahary N, Whiting S, Lopez CD, Sun W, Charpentier K, Shipley J, Anderson E, McNulty B, Schumacher A, Clark A, Vakharia J, Kennedy T, Sio T.
Safran H, et al. Among authors: schumacher a.
Am J Clin Oncol. 2011 Feb;34(1):50-2. doi: 10.1097/coc.0b013e3181d26b01.
Am J Clin Oncol. 2011.
PMID: 24757739
Clinical Trial.